首页 > 最新文献

International Journal of Immunogenetics最新文献

英文 中文
Association between PTPN22 C1858T polymorphism and juvenile idiopathic arthritis: A meta-analysis update with trial sequential analysis PTPN22 C1858T多态性与青少年特发性关节炎的关系:一项荟萃分析更新试验序列分析
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-07-22 DOI: 10.1111/iji.12590
Young Ho Lee, Gwan Gyu Song

Our aim was to determine whether protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858T polymorphism (rs2476601) is associated with susceptibility to juvenile idiopathic arthritis (JIA). MEDLINE and EMBASE databases were searched to identify articles in which PTPN22 C1858T polymorphism was reported to be identified in JIA patients and controls. A meta-analysis was conducted to evaluate the association between PTPN22 C1858T polymorphism and RA using allelic contrast. Trial sequential analysis (TSA) was performed. Sixteen separate comparisons involving 5696 JIA patients and 9483 controls (a total of 15,179 subjects) were considered in this meta-analysis. A meta-analysis was performed with all JIA patients as well as JIA patients in each ethnic group. Meta-analysis revealed an association between the T allele of PTPN22 C1858T polymorphism and JIA in all subjects (OR, 1.322; 95% CI, 1.233–1.418; p < .001). Analysis after stratification by ethnicity indicated that the T allele was significantly associated with JIA in the European population (OR, 1.312; 95% CI, 1.2211–1.410; p < .001). However, analysis performed in the non-European population showed no significant association between the T allele and JIA. TSA indicated that the observed association between the PTPN22 polymorphism and JIA in all subjects and the European population is consistent with the existing evidence. This meta-analysis confirms that PTPN22 C1858T polymorphism is associated with susceptibility to JIA in Europeans, and that no additional studies are needed to verify these results. However, current evidence in the non-European population is insufficient, and further studies are warranted.

我们的目的是确定蛋白酪氨酸磷酸酶非受体22 (PTPN22) C1858T多态性(rs2476601)是否与幼年特发性关节炎(JIA)易感性相关。检索MEDLINE和EMBASE数据库,找出JIA患者和对照组中发现PTPN22 C1858T多态性的文章。采用等位基因对比对PTPN22 C1858T多态性与RA的相关性进行meta分析。进行试验序列分析(TSA)。本荟萃分析考虑了16个独立的比较,涉及5696例JIA患者和9483例对照(共15179名受试者)。对所有JIA患者以及各民族JIA患者进行meta分析。meta分析显示PTPN22 C1858T多态性的T等位基因与JIA在所有受试者中存在相关性(OR, 1.322;95% ci, 1.233-1.418;p & lt;措施)。种族分层后的分析表明,T等位基因与欧洲人群的JIA显著相关(OR, 1.312;95% ci, 1.2211-1.410;p & lt;措施)。然而,在非欧洲人群中进行的分析显示,T等位基因与JIA之间没有显著关联。TSA表明,观察到的PTPN22多态性与JIA在所有受试者和欧洲人群中的相关性与现有证据一致。该荟萃分析证实了PTPN22 C1858T多态性与欧洲人JIA易感性相关,不需要进一步的研究来验证这些结果。然而,目前在非欧洲人口中的证据不足,需要进一步的研究。
{"title":"Association between PTPN22 C1858T polymorphism and juvenile idiopathic arthritis: A meta-analysis update with trial sequential analysis","authors":"Young Ho Lee,&nbsp;Gwan Gyu Song","doi":"10.1111/iji.12590","DOIUrl":"10.1111/iji.12590","url":null,"abstract":"<p>Our aim was to determine whether protein tyrosine phosphatase nonreceptor 22 (<i>PTPN22</i>) C1858T polymorphism (rs2476601) is associated with susceptibility to juvenile idiopathic arthritis (JIA). MEDLINE and EMBASE databases were searched to identify articles in which <i>PTPN22</i> C1858T polymorphism was reported to be identified in JIA patients and controls. A meta-analysis was conducted to evaluate the association between <i>PTPN22</i> C1858T polymorphism and RA using allelic contrast. Trial sequential analysis (TSA) was performed. Sixteen separate comparisons involving 5696 JIA patients and 9483 controls (a total of 15,179 subjects) were considered in this meta-analysis. A meta-analysis was performed with all JIA patients as well as JIA patients in each ethnic group. Meta-analysis revealed an association between the T allele of <i>PTPN22</i> C1858T polymorphism and JIA in all subjects (OR, 1.322; 95% CI, 1.233–1.418; <i>p</i> &lt; .001). Analysis after stratification by ethnicity indicated that the T allele was significantly associated with JIA in the European population (OR, 1.312; 95% CI, 1.2211–1.410; <i>p</i> &lt; .001). However, analysis performed in the non-European population showed no significant association between the T allele and JIA. TSA indicated that the observed association between the <i>PTPN22</i> polymorphism and JIA in all subjects and the European population is consistent with the existing evidence. This meta-analysis confirms that <i>PTPN22</i> C1858T polymorphism is associated with susceptibility to JIA in Europeans, and that no additional studies are needed to verify these results. However, current evidence in the non-European population is insufficient, and further studies are warranted.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40545162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VDR gene polymorphisms are associated with the increased susceptibility to COVID-19 among iranian population: A case-control study 伊朗人群中VDR基因多态性与COVID-19易感性增加有关:一项病例对照研究
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-07-21 DOI: 10.1111/iji.12585
Ali Jafarpoor, Seyed Mohammad Jazayeri, Farah Bokharaei-Salim, Angila Ataei-Pirkooh, Azam Ghaziasadi, Saber Soltani, Ahmadreza Sadeghi, Shima Sadeghipoor Marvi, Vahdat Poortahmasebi, Seyed Mahmood Seyed Khorrami, Mandana Hasanzad, Negar Parsania, Sina Nagozir, Narges Mokhtari, Ali Parsania, Asma Bahrami, Mohammad Hossein Nadjarha, Reza Pakzad, Masoud Parsania

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the pathogenesis is unclear. Host genetic background is one of the main factors influencing the patients' susceptibility to several viral infectious diseases. This study aimed to investigate the association between host genetic polymorphisms of two genes, including vitamin D receptor (VDR) and vitamin D binding protein (DBP), and susceptibility to COVID-19 in a sample of the Iranian population. This case-control study enrolled 188 hospitalized COVID-19 patients as the case group and 218 suspected COVID-19 patients with mild signs as the control group. The VDR (rs7975232, rs731236 and rs2228570) and DBP (rs7041) gene single nucleotide polymorphisms (SNPs) were genotyped by Polymerase Chain Reaction Restriction – Fragment Length Polymorphism (PCR-RFLP) method. A significant association between rs2228570 SNP in the VDR gene and the susceptibility of COVID-19 was found between case and control groups. The CT genotype (Heterozygous) of rs2228570 C > T polymorphism showed significant association with a 3.088 fold increased odds of COVID-19 (p < .0001; adjusted OR: 3.088; 95% CI: 1.902–5.012). In addition, a significant association between CC genotype of rs2228570 CT polymorphism and increased odds of COVID-19 in male and female groups (p = .001; adjusted OR: 3.125; 95% CI: 1.630–5.991 and p = .002; adjusted OR: 3.071; 95% CI: 1.485–6.354 respectively) were determined. Our results revealed no significant differences in the frequency of genotype and allele of VDR (rs7975232 and rs731236) and DBP (rs7041) between SARS-CoV-2-infected patients and controls (p > .05). Our results showed that polymorphism of VDR (rs2228570) probably could influence individual susceptibility to COVID-19. The polymorphisms of VDR (rs7975232 and rs731236) and DBP (rs7041) were not associated with SARS-CoV-2 infection susceptibility.

冠状病毒病2019 (COVID-19)是一种由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的传染病,其发病机制尚不清楚。宿主遗传背景是影响患者对几种病毒性传染病易感性的主要因素之一。本研究旨在调查伊朗人群样本中维生素D受体(VDR)和维生素D结合蛋白(DBP)两种基因的宿主遗传多态性与COVID-19易感性之间的关系。本病例对照研究选取188例住院新冠肺炎患者为病例组,218例轻度体征疑似新冠肺炎患者为对照组。采用聚合酶链反应限制性片段长度多态性(PCR-RFLP)方法对VDR (rs7975232、rs731236和rs2228570)和DBP (rs7041)基因单核苷酸多态性(snp)进行分型。在病例组和对照组之间,发现VDR基因rs2228570 SNP与COVID-19易感性之间存在显著关联。rs2228570c >的CT基因型(杂合);T多态性与COVID-19发病率增加3.088倍显著相关(p <。;调整OR: 3.088;95% ci: 1.902-5.012)。此外,rs2228570 CT多态性CC基因型与男性和女性组COVID-19发病率增加之间存在显著相关性(p = .001;调整OR: 3.125;95% CI: 1.630 ~ 5.991, p = 0.002;调整OR: 3.071;95% CI分别为1.485-6.354)。我们的研究结果显示,在sars - cov -2感染患者和对照组之间,VDR (rs7975232和rs731236)和DBP (rs7041)的基因型和等位基因频率无显著差异(p >. 05)。我们的结果表明,VDR (rs2228570)多态性可能影响个体对COVID-19的易感性。VDR (rs7975232和rs731236)和DBP (rs7041)多态性与SARS-CoV-2感染易感性无相关性。
{"title":"VDR gene polymorphisms are associated with the increased susceptibility to COVID-19 among iranian population: A case-control study","authors":"Ali Jafarpoor,&nbsp;Seyed Mohammad Jazayeri,&nbsp;Farah Bokharaei-Salim,&nbsp;Angila Ataei-Pirkooh,&nbsp;Azam Ghaziasadi,&nbsp;Saber Soltani,&nbsp;Ahmadreza Sadeghi,&nbsp;Shima Sadeghipoor Marvi,&nbsp;Vahdat Poortahmasebi,&nbsp;Seyed Mahmood Seyed Khorrami,&nbsp;Mandana Hasanzad,&nbsp;Negar Parsania,&nbsp;Sina Nagozir,&nbsp;Narges Mokhtari,&nbsp;Ali Parsania,&nbsp;Asma Bahrami,&nbsp;Mohammad Hossein Nadjarha,&nbsp;Reza Pakzad,&nbsp;Masoud Parsania","doi":"10.1111/iji.12585","DOIUrl":"10.1111/iji.12585","url":null,"abstract":"<p>Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the pathogenesis is unclear. Host genetic background is one of the main factors influencing the patients' susceptibility to several viral infectious diseases. This study aimed to investigate the association between host genetic polymorphisms of two genes, including vitamin D receptor (VDR) and vitamin D binding protein (DBP), and susceptibility to COVID-19 in a sample of the Iranian population. This case-control study enrolled 188 hospitalized COVID-19 patients as the case group and 218 suspected COVID-19 patients with mild signs as the control group. The VDR (rs7975232, rs731236 and rs2228570) and DBP (rs7041) gene single nucleotide polymorphisms (SNPs) were genotyped by Polymerase Chain Reaction Restriction – Fragment Length Polymorphism (PCR-RFLP) method. A significant association between rs2228570 SNP in the VDR gene and the susceptibility of COVID-19 was found between case and control groups. The CT genotype (Heterozygous) of rs2228570 C &gt; T polymorphism showed significant association with a 3.088 fold increased odds of COVID-19 (<i>p</i> &lt; .0001; adjusted OR: 3.088; 95% CI: 1.902–5.012). In addition, a significant association between CC genotype of rs2228570 CT polymorphism and increased odds of COVID-19 in male and female groups (<i>p</i> = .001; adjusted OR: 3.125; 95% CI: 1.630–5.991 and <i>p</i> = .002; adjusted OR: 3.071; 95% CI: 1.485–6.354 respectively) were determined. Our results revealed no significant differences in the frequency of genotype and allele of VDR (rs7975232 and rs731236) and DBP (rs7041) between SARS-CoV-2-infected patients and controls (<i>p</i> &gt; .05). Our results showed that polymorphism of VDR (rs2228570) probably could influence individual susceptibility to COVID-19. The polymorphisms of VDR (rs7975232 and rs731236) and DBP (rs7041) were not associated with SARS-CoV-2 infection susceptibility.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350092/pdf/IJI-49-243.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40612857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Nomenclature for factors of the HLA system, update April, May and June 2022 HLA系统因子命名法,2022年4月、5月和6月更新
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-07-21 DOI: 10.1111/iji.12591
Steven G. E. Marsh
The following sequences have been submitted to the Nomenclature Committee since the January, February and March 2022 nomenclature update (Marsh, 2022) and, following agreed policy, have been assigned official allele designations (Marsh et al., 2010). Full details of all sequences will be published in a forthcoming report. Below are listed the newly assigned sequences (Table 1) and confirmations of previously reported sequences (Table 2). The accession number of each sequence is given and these can be used to retrieve the sequence files from the EMBL, GenBank or DDBJ data libraries. Although accession numbers have been assigned by the data libraries and most sequences are already available, there is still the possibility that an author may not yet have allowed the sequence to be released; in such a case, you will have to contact the submitting author directly. Additional information pertaining to new sequences is often included in the publications describing these alleles; a listing of recent publications that describe new HLA sequences is given in Table 3. In addition, the sequence for the allele C*16:15:01 has been extended to become a new C*16 protein variant. The allele name C*16:15:01has been abandoned and the sequence renamedC*16:201. Furthermore, the allele DPA1*02:64 was found to have an alternative start codon, and has had theQ suffix added, to becomeDPA1*02:64Q. All new and confirmatory sequences should now be submitted directly to the WHO Nomenclature Committee for Factors of the HLA System via the IPD-IMGT/HLADatabase using the sequence submission tool provided (Robinson et al., 2020). The IPD-IMGT/HLA Databasemay be accessed via theWorldWideWeb at: www.ebi.ac.uk/ ipd/imgt/hla.
{"title":"Nomenclature for factors of the HLA system, update April, May and June 2022","authors":"Steven G. E. Marsh","doi":"10.1111/iji.12591","DOIUrl":"10.1111/iji.12591","url":null,"abstract":"The following sequences have been submitted to the Nomenclature Committee since the January, February and March 2022 nomenclature update (Marsh, 2022) and, following agreed policy, have been assigned official allele designations (Marsh et al., 2010). Full details of all sequences will be published in a forthcoming report. Below are listed the newly assigned sequences (Table 1) and confirmations of previously reported sequences (Table 2). The accession number of each sequence is given and these can be used to retrieve the sequence files from the EMBL, GenBank or DDBJ data libraries. Although accession numbers have been assigned by the data libraries and most sequences are already available, there is still the possibility that an author may not yet have allowed the sequence to be released; in such a case, you will have to contact the submitting author directly. Additional information pertaining to new sequences is often included in the publications describing these alleles; a listing of recent publications that describe new HLA sequences is given in Table 3. In addition, the sequence for the allele C*16:15:01 has been extended to become a new C*16 protein variant. The allele name C*16:15:01has been abandoned and the sequence renamedC*16:201. Furthermore, the allele DPA1*02:64 was found to have an alternative start codon, and has had theQ suffix added, to becomeDPA1*02:64Q. All new and confirmatory sequences should now be submitted directly to the WHO Nomenclature Committee for Factors of the HLA System via the IPD-IMGT/HLADatabase using the sequence submission tool provided (Robinson et al., 2020). The IPD-IMGT/HLA Databasemay be accessed via theWorldWideWeb at: www.ebi.ac.uk/ ipd/imgt/hla.","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40612858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India NLRP3炎症小体基因的易感性单倍型影响印度旁遮普人群缺血性卒中的风险
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-07-21 DOI: 10.1111/iji.12589
Nitin Kumar, Manminder Kaur, Gurjinderpal Singh, Srishti Valecha, Rubanpal Khinda, Mario Di Napoli, Monica Singh, Puneetpal Singh, Sarabjit Mastana

Despite strong genetic implications of NLRP3 inflammasome, its examination as genetic determinant of ischaemic stroke (IS) remains to be done in Punjab, which has been investigated in this study. In this case control study, 400 subjects (200 IS patients, 200 stroke free controls) were included. Contributions of 5 single nucleotide polymorphisms (SNPs) including a functional SNP within NLRP3 gene (rs10754558, rs4612666, rs2027432, rs3738488 and rs1539019) for the risk of IS were investigated through genetic models after correcting the effect of significant variables. Plasma levels of three pro-inflammatory markers, that is, C-reactive protein (CRP), interleukin-1beta (IL-1β) and interleukin-18 (IL-18) were measured by enzyme-linked immunosorbent assays (ELISA). Minor alleles of 3 out of 5 SNPs (rs10754558, rs4612666 and rs1539019) exhibited association with IS risk in additive, recessive and multiplicative models. Multivariable regression analysis confirmed that higher levels of systolic blood pressure (β ± SE: 1.42 ± 0.57, p = .013), CRP (β ± SE: 1.22 ± 0.41, p = .003), IL-1β (β ± SE: 1.78 ± 0.88, p = .043) and IL-18 (β ± SE: 1.13 ± 0.49, p = .021) were independent risk predictors for IS. Haplotype analysis revealed a susceptibility putative haplotype GTGTA, which approximately doubled the IS risk (OR: 1.98, 95% CI: 1.12–3.78, p = .04) in dominant mode after adjusting the effect with confounding variables. This susceptibility putative haplotype GTGTA was significantly associated with increased concentrations of CRP (β = 1.21, p = .014) and IL-1β (β = 1.53, p = .034) in dose-dependent manner (less in carriers of 1 copy than those who had 2 copies of GTGTA).

The present study has revealed a susceptibility putative haplotype GTGTA within NLRP3 gene, carriers of which have double the risk of IS by having increased plasma levels of CRP and IL-1β in a dose-dependent manner.

尽管NLRP3炎性体具有很强的遗传意义,但其作为缺血性卒中(IS)遗传决定因素的检测仍有待于在旁遮普进行,本研究已对此进行了调查。在本病例对照研究中,纳入了400名受试者(200名IS患者和200名无卒中对照)。在校正显著变量的影响后,通过遗传模型研究了包括NLRP3基因内一个功能SNP在内的5个单核苷酸多态性(rs10754558、rs4612666、rs2027432、rs3738488和rs1539019)对IS风险的贡献。采用酶联免疫吸附法(ELISA)检测血浆中c反应蛋白(CRP)、白细胞介素-1β (IL-1β)和白细胞介素-18 (IL-18) 3种促炎标志物的水平。5个snp中有3个的次要等位基因(rs10754558、rs4612666和rs1539019)在加性、隐性和乘法模型中显示与IS风险相关。多变量回归分析证实,较高的收缩压(β±SE: 1.42±0.57,p = 0.013)、CRP (β±SE: 1.22±0.41,p = 0.003)、IL-1β (β±SE: 1.78±0.88,p = 0.043)和IL-18 (β±SE: 1.13±0.49,p = 0.021)水平是IS的独立危险预测因素。单倍型分析显示,假定的单倍型GTGTA易感性,在调整混杂变量的影响后,优势模式下,其IS风险约增加一倍(OR: 1.98, 95% CI: 1.12-3.78, p = 0.04)。这种推测的GTGTA单倍型易感性与CRP (β = 1.21, p = 0.014)和IL-1β (β = 1.53, p = 0.034)浓度的增加呈剂量依赖性(1拷贝GTGTA携带者比2拷贝GTGTA携带者少)显著相关。本研究揭示了NLRP3基因中假定的单倍型GTGTA易感性,其携带者血浆CRP和IL-1β水平呈剂量依赖性增加,使IS的风险增加一倍。
{"title":"A susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India","authors":"Nitin Kumar,&nbsp;Manminder Kaur,&nbsp;Gurjinderpal Singh,&nbsp;Srishti Valecha,&nbsp;Rubanpal Khinda,&nbsp;Mario Di Napoli,&nbsp;Monica Singh,&nbsp;Puneetpal Singh,&nbsp;Sarabjit Mastana","doi":"10.1111/iji.12589","DOIUrl":"10.1111/iji.12589","url":null,"abstract":"<p>Despite strong genetic implications of NLRP3 inflammasome, its examination as genetic determinant of ischaemic stroke (IS) remains to be done in Punjab, which has been investigated in this study. In this case control study, 400 subjects (200 IS patients, 200 stroke free controls) were included. Contributions of 5 single nucleotide polymorphisms (SNPs) including a functional SNP within NLRP3 gene (rs10754558, rs4612666, rs2027432, rs3738488 and rs1539019) for the risk of IS were investigated through genetic models after correcting the effect of significant variables. Plasma levels of three pro-inflammatory markers, that is, C-reactive protein (CRP), interleukin-1beta (IL-1β) and interleukin-18 (IL-18) were measured by enzyme-linked immunosorbent assays (ELISA). Minor alleles of 3 out of 5 SNPs (rs10754558, rs4612666 and rs1539019) exhibited association with IS risk in additive, recessive and multiplicative models. Multivariable regression analysis confirmed that higher levels of systolic blood pressure (<i>β</i> ± SE: 1.42 ± 0.57, <i>p</i> = .013), CRP (<i>β</i> ± SE: 1.22 ± 0.41, <i>p</i> = .003), IL-1β (<i>β</i> ± SE: 1.78 ± 0.88, <i>p</i> = .043) and IL-18 (<i>β</i> ± SE: 1.13 ± 0.49, <i>p</i> = .021) were independent risk predictors for IS. Haplotype analysis revealed a susceptibility putative haplotype GTGTA, which approximately doubled the IS risk (OR: 1.98, 95% CI: 1.12–3.78, <i>p</i> = .04) in dominant mode after adjusting the effect with confounding variables. This susceptibility putative haplotype GTGTA was significantly associated with increased concentrations of CRP (<i>β</i> = 1.21, <i>p</i> = .014) and IL-1β (<i>β</i> = 1.53, <i>p</i> = .034) in dose-dependent manner (less in carriers of 1 copy than those who had 2 copies of GTGTA).</p><p>The present study has revealed a susceptibility putative haplotype GTGTA within NLRP3 gene, carriers of which have double the risk of IS by having increased plasma levels of CRP and IL-1β in a dose-dependent manner.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/a5/IJI-49-260.PMC9546049.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40613817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association between interleukin-1 receptor antagonist (IL-1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web-based analysis 伊朗人群中白细胞介素-1受体拮抗剂(IL-1ra) VNTR、基因多态性和乳腺癌易感性之间的关系:实验和网络分析
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-07-15 DOI: 10.1111/iji.12584
Reza Ibrahimi, Mostafa Ibrahimi, Behzad jamalzei, Mohammad Esmaeil Akbari, Mohsen Navari, Maryam Moossavi, Milad Khorasani

Breast cancer is one of the leading causes of cancer mortality. Growing evidence indicates that interleukins and its polymorphisms are involved in the pathogenesis of breast cancer. Variable number of tandem repeat (VNTR) polymorphism can affect transcription rate, mRNA stability and also the resulting protein expression and activity. Hence, present study aimed to assess the possible association between interleukin-1 receptor antagonist (IL-1Ra) VNTR polymorphism, and breast cancer susceptibility in Iranian population. A total of 300 Iranian individuals, 150 breast cancer patients and 150 age-matched healthy women, were included in this study. DNA extracted by salting out method and genotyping was done using the polymerase chain reaction. The frequency of the allele 2(5% vs. 22%) and the 2/2 genotype (22% vs. 46%) of IL-1Ra VNTR polymorphism was significantly higher in healthy control compared to breast cancer patient: therefore, A2 allele may play a protective role against breast cancer and its progression (p = .0001 and OR = 0.105, 95% CI: [0.044–0.248]). The allele 2 and 2/2 genotype of the IL-Ra VNTR polymorphism can be a protective factor against breast cancer susceptibility.

乳腺癌是导致癌症死亡的主要原因之一。越来越多的证据表明,白细胞介素及其多态性参与了乳腺癌的发病机制。可变数目串联重复序列(VNTR)多态性可以影响转录率、mRNA的稳定性以及由此产生的蛋白的表达和活性。因此,本研究旨在评估白细胞介素-1受体拮抗剂(IL-1Ra) VNTR多态性与伊朗人群乳腺癌易感性之间的可能关联。这项研究共包括300名伊朗人、150名乳腺癌患者和150名年龄匹配的健康妇女。用盐析法提取DNA,用聚合酶链反应进行基因分型。与乳腺癌患者相比,健康对照组IL-1Ra VNTR多态性等位基因2(5% vs 22%)和2/2基因型(22% vs 46%)的频率显著高于乳腺癌患者,因此A2等位基因可能对乳腺癌及其进展具有保护作用(p = 0.0001, OR = 0.105, 95% CI:[0.044-0.248])。IL-Ra VNTR多态性的等位基因2和2/2基因型可能是乳腺癌易感性的保护因素。
{"title":"Association between interleukin-1 receptor antagonist (IL-1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web-based analysis","authors":"Reza Ibrahimi,&nbsp;Mostafa Ibrahimi,&nbsp;Behzad jamalzei,&nbsp;Mohammad Esmaeil Akbari,&nbsp;Mohsen Navari,&nbsp;Maryam Moossavi,&nbsp;Milad Khorasani","doi":"10.1111/iji.12584","DOIUrl":"10.1111/iji.12584","url":null,"abstract":"<p>Breast cancer is one of the leading causes of cancer mortality. Growing evidence indicates that interleukins and its polymorphisms are involved in the pathogenesis of breast cancer. Variable number of tandem repeat (VNTR) polymorphism can affect transcription rate, mRNA stability and also the resulting protein expression and activity. Hence, present study aimed to assess the possible association between interleukin-1 receptor antagonist (IL-1Ra) VNTR polymorphism, and breast cancer susceptibility in Iranian population. A total of 300 Iranian individuals, 150 breast cancer patients and 150 age-matched healthy women, were included in this study. DNA extracted by salting out method and genotyping was done using the polymerase chain reaction. The frequency of the allele 2(5% vs. 22%) and the 2/2 genotype (22% vs. 46%) of IL-1Ra VNTR polymorphism was significantly higher in healthy control compared to breast cancer patient: therefore, A2 allele may play a protective role against breast cancer and its progression (<i>p</i> = .0001 and OR = 0.105, 95% CI: [0.044–0.248]). The allele 2 and 2/2 genotype of the IL-Ra VNTR polymorphism can be a protective factor against breast cancer susceptibility.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40524906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Differential distribution of vitamin D receptor (VDR) gene variants and its expression in systemic lupus erythematosus 维生素D受体(VDR)基因变异在系统性红斑狼疮中的差异分布及其表达
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-05-12 DOI: 10.1111/iji.12576
Jaqueline De Azevêdo Silva, Suelen Cristina de Lima, Thiago Sotero Fragoso, Catarina Addobbati Jordão Cavalcanti, Alexandre Domingues Barbosa, Maria Eduarda de Albuquerque Borborema, Thays Maria Costa de Lucena, Angela Luzia Branco Pinto Duarte, Sergio Crovella, Paula Sandrin-Garcia

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder that displays an important genetic background. Vitamin D3 (VD3) through its receptor (VDR) plays an important immunomodulatory role in autoimmune misbalance, being capable of modulating immune responses. Genetic alterations in VDR gene may contribute to an altered risk in SLE development and clinical manifestations. We investigated VDR SNPs (single nucleotide polymorphisms) frequencies in 128 SLE patients and 138 healthy controls (HC) and mRNA differential expression in 29 patients and 17 HC regarding SLE susceptibility as well as clinical features. We observed that rs11168268 G allele (OR = 1.55, = .01) and G/G genotype (OR = 2.69, = .008) were associated with increased SLE susceptibility. The rs2248098 G allele and A/G and G/G genotypes were associated to lower SLE susceptibility (OR = 0.66, = .01; OR = 0.46, = .01; OR = 0.44, = .02, respectively). Regarding clinical features, we observed lower risk for: rs11168268 A/G genotype and nephritis (OR = 0.31, = .01); rs4760648 T/T genotype and photosensitivity (OR = 0.24, = .02); rs1540339 T/T genotype and antibody anti-dsDNA (OR = 0.19, = .015); rs3890733 T/T genotype and serositis (OR = 0.10, = .01). We identified a significant downregulation in VDR expression levels when compared patients and controls overall (= 1.04e–7), in Cdx-2 A/G and G/G (= .008 and = .014, respectively) and in patients with nephritis (= .016)

Our results suggested that VDR SNPs influence upon SLE susceptibility and in particular clinical features, acting on mRNA expression in SLE patients overall and the ones with nephritis.

系统性红斑狼疮(SLE)是一种多因素自身免疫性疾病,具有重要的遗传背景。维生素D3 (VD3)通过其受体(VDR)在自身免疫失衡中起重要的免疫调节作用,能够调节免疫应答。VDR基因的遗传改变可能导致SLE发展和临床表现的风险改变。我们研究了128例SLE患者和138例健康对照(HC)的VDR snp(单核苷酸多态性)频率,以及29例患者和17例HC中与SLE易感性和临床特征相关的mRNA差异表达。我们观察到rs11168268 G等位基因(OR = 1.55, p = 0.01)和G/G基因型(OR = 2.69, p = 0.008)与SLE易感性增加相关。rs2248098 G等位基因、A/G和G/G基因型与SLE易感性降低相关(OR = 0.66, p = 0.01;OR = 0.46, p = 0.01;OR = 0.44, p = 0.02)。关于临床特征,我们观察到:rs11168268 A/G基因型和肾炎的风险较低(OR = 0.31, p = 0.01);rs4760648 T/T基因型与光敏性(OR = 0.24, p = 0.02);rs1540339 T/T基因型和抗体抗dsdna (OR = 0.19, p = 0.015);T/T基因型与血清炎的相关性(OR = 0.10, p = 0.01)。我们发现VDR的表达水平在患者和对照组的总体比较(p = 1.04e-7)、Cdx-2 a /G和G/G的表达水平(p = 0.008和p = 0.014)以及肾炎患者的表达水平(p = 0.016)均显著下调。我们的研究结果表明,VDR snp影响SLE的易感性,特别是临床特征,作用于SLE患者和肾炎患者的mRNA表达。
{"title":"Differential distribution of vitamin D receptor (VDR) gene variants and its expression in systemic lupus erythematosus","authors":"Jaqueline De Azevêdo Silva,&nbsp;Suelen Cristina de Lima,&nbsp;Thiago Sotero Fragoso,&nbsp;Catarina Addobbati Jordão Cavalcanti,&nbsp;Alexandre Domingues Barbosa,&nbsp;Maria Eduarda de Albuquerque Borborema,&nbsp;Thays Maria Costa de Lucena,&nbsp;Angela Luzia Branco Pinto Duarte,&nbsp;Sergio Crovella,&nbsp;Paula Sandrin-Garcia","doi":"10.1111/iji.12576","DOIUrl":"10.1111/iji.12576","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder that displays an important genetic background. Vitamin D<sub>3</sub> (VD<sub>3</sub>) through its receptor (VDR) plays an important immunomodulatory role in autoimmune misbalance, being capable of modulating immune responses. Genetic alterations in <i>VDR</i> gene may contribute to an altered risk in SLE development and clinical manifestations. We investigated <i>VDR</i> SNPs (single nucleotide polymorphisms) frequencies in 128 SLE patients and 138 healthy controls (HC) and mRNA differential expression in 29 patients and 17 HC regarding SLE susceptibility as well as clinical features. We observed that rs11168268 G allele (OR = 1.55, <i>p </i>= .01) and G/G genotype (OR = 2.69, <i>p </i>= .008) were associated with increased SLE susceptibility. The rs2248098 G allele and A/G and G/G genotypes were associated to lower SLE susceptibility (OR = 0.66, <i>p </i>= .01; OR = 0.46, <i>p </i>= .01; OR = 0.44, <i>p </i>= .02, respectively). Regarding clinical features, we observed lower risk for: rs11168268 A/G genotype and nephritis (OR = 0.31, <i>p </i>= .01); rs4760648 T/T genotype and photosensitivity (OR = 0.24, <i>p </i>= .02); rs1540339 T/T genotype and antibody anti-dsDNA (OR = 0.19, <i>p </i>= .015); rs3890733 T/T genotype and serositis (OR = 0.10, <i>p </i>= .01). We identified a significant downregulation in <i>VDR</i> expression levels when compared patients and controls overall (<i>p </i>= 1.04e<sup>–7</sup>), in <i>Cdx-2</i> A/G and G/G (<i>p </i>= .008 and <i>p </i>= .014, respectively) and in patients with nephritis (<i>p </i>= .016)</p>\u0000 \u0000 <p>Our results suggested that <i>VDR</i> SNPs influence upon SLE susceptibility and in particular clinical features, acting on mRNA expression in SLE patients overall and the ones with nephritis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44637560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prevalence of Rh and K phenotypes among blood donors from different ethnicities in Samtah (Southwestern Region) Saudi Arabia 沙特阿拉伯Samtah(西南地区)不同种族献血者Rh和K表型患病率
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-05-05 DOI: 10.1111/iji.12577
Hassan A. Hamali, Maymoon M. Madkhali, Gasim Dobie, Aymen M. Madkhali, Basem Madkhali, Yahia Hummadi, Abdullah Meshi, Mohammad S. Akhter, Abdullah A. Mobarki, Muhammad Saboor

Introduction: Rh and Kell blood group systems are amongst the most important blood group systems; being highly immunogenic after ABO system. The aim of this study was to evaluate the frequencies of Rh antigens, haplotypes and K antigen among blood donors belonging to various ethnicities in Samtah, Jazan, Saudi Arabia.

Methods: This study was conducted during January 2019 and August 2020 at Samtah General Hospital, Samtah. Records of all blood donors recruited during this period were included for data acquisition. A total of 4977 blood donors’ records were reviewed and data were analysed. A total of 3863 donors’ results were considered in the final analysis.

Results: In comparison to Saudi blood donors, C antigen was less frequent in Sudanese donors (69.7% and 34.0%), the c antigen was less frequent in Indian (79.2% and 59.3%) and Philippine (79.2% and 40.0%) donors and more frequent in Sudanese (79.2% and 97.9%) donors, the E antigen was less frequent in Yemini (27.0% and 19.5%) and the e antigen was more frequent in Yemini (96.7% and 99.2%) donors. The DcE haplotype was less frequent (3.1% and 0.7%) and the ce haplotype was more frequent (4.3% and 7.6%) in Yemini donors. The K antigen was less frequent in Pakistani (11.9% and 4.1%; p = .041) and Indian (11.9% and 1.9%; p = .023) donors.

Conclusion: Rh and K antigens showed marked variations in their frequencies among blood donors of different ethnicities. Utilization of blood from various ethnicities warrant extended phenotyping of Rh and K antigens to avoid the risk of alloimmunization in multiply transfused patients.

Rh和Kell血型系统是最重要的血型系统;经ABO系统免疫原性高。本研究的目的是评估在沙特阿拉伯吉赞Samtah不同种族的献血者中Rh抗原、单倍型和K抗原的频率。方法:本研究于2019年1月至2020年8月在Samtah综合医院进行。在此期间招募的所有献血者的记录被纳入数据获取。总共审查了4977名献血者的记录并分析了数据。在最后的分析中,总共考虑了3863名捐赠者的结果。结果:与沙特献血者相比,苏丹献血者C抗原较少(69.7%和34.0%),印度献血者C抗原较少(79.2%和59.3%),菲律宾献血者C抗原较少(79.2%和40.0%),苏丹献血者C抗原较多(79.2%和97.9%),也门献血者E抗原较少(27.0%和19.5%),也门献血者E抗原较多(96.7%和99.2%)。在也门献血者中,DcE单倍型发生率较低(3.1%和0.7%),ce单倍型发生率较高(4.3%和7.6%)。K抗原在巴基斯坦较少,分别为11.9%和4.1%;p = 0.041)和印度人(11.9%和1.9%;P = 0.023)。结论:Rh、K抗原在不同种族献血者中出现频率存在显著差异。利用来自不同种族的血液,需要延长Rh和K抗原的表型,以避免多次输血患者的同种异体免疫风险。
{"title":"Prevalence of Rh and K phenotypes among blood donors from different ethnicities in Samtah (Southwestern Region) Saudi Arabia","authors":"Hassan A. Hamali,&nbsp;Maymoon M. Madkhali,&nbsp;Gasim Dobie,&nbsp;Aymen M. Madkhali,&nbsp;Basem Madkhali,&nbsp;Yahia Hummadi,&nbsp;Abdullah Meshi,&nbsp;Mohammad S. Akhter,&nbsp;Abdullah A. Mobarki,&nbsp;Muhammad Saboor","doi":"10.1111/iji.12577","DOIUrl":"10.1111/iji.12577","url":null,"abstract":"<p>Introduction: Rh and Kell blood group systems are amongst the most important blood group systems; being highly immunogenic after ABO system. The aim of this study was to evaluate the frequencies of Rh antigens, haplotypes and K antigen among blood donors belonging to various ethnicities in Samtah, Jazan, Saudi Arabia.</p><p>Methods: This study was conducted during January 2019 and August 2020 at Samtah General Hospital, Samtah. Records of all blood donors recruited during this period were included for data acquisition. A total of 4977 blood donors’ records were reviewed and data were analysed. A total of 3863 donors’ results were considered in the final analysis.</p><p>Results: In comparison to Saudi blood donors, C antigen was less frequent in Sudanese donors (69.7% and 34.0%), the c antigen was less frequent in Indian (79.2% and 59.3%) and Philippine (79.2% and 40.0%) donors and more frequent in Sudanese (79.2% and 97.9%) donors, the E antigen was less frequent in Yemini (27.0% and 19.5%) and the e antigen was more frequent in Yemini (96.7% and 99.2%) donors. The DcE haplotype was less frequent (3.1% and 0.7%) and the ce haplotype was more frequent (4.3% and 7.6%) in Yemini donors. The K antigen was less frequent in Pakistani (11.9% and 4.1%; <i>p</i> = .041) and Indian (11.9% and 1.9%; <i>p</i> = .023) donors.</p><p>Conclusion: Rh and K antigens showed marked variations in their frequencies among blood donors of different ethnicities. Utilization of blood from various ethnicities warrant extended phenotyping of Rh and K antigens to avoid the risk of alloimmunization in multiply transfused patients.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44934300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nomenclature for factors of the HLA system, update January, February and March 2022 HLA系统因子命名法,2022年1月、2月和3月更新
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-05-01 DOI: 10.1111/iji.12575
Steven G. E. Marsh
The following sequences have been submitted to the Nomenclature Committee since theOctober, November andDecember 2021 nomenclature update (Marsh, 2022) and, following agreed policy, have been assigned official allele designations (Marsh et al., 2010). Full details of all sequences will be published in a forthcoming report. Below are listed the newly assigned sequences (Table 1) and confirmations of previously reported sequences (Table 2). The accession number of each sequence is given and these can be used to retrieve the sequence files from the EMBL, GenBank or DDBJ data libraries. Although accession numbers have been assigned by the data-libraries and most sequences are already available, there is still the possibility that an author may not yet have allowed the sequence to be released; in such a case you will have to contact the submitting author directly. Additional information pertaining to new sequences is often included in the publications describing these alleles; a listing of recent publications that describe new HLA sequences is given in Table 3. An additional 295 alleles were recently published but have not been included in Table 3 due to space considerations (Turner et al., 2022). In addition, the sequence for the allele A*02:01:08 has been extended to become a new A*02 protein variant. The allele name A*02:01:08 has been abandoned and the sequence renamed A*02:1040. Furthermore, the sequence for the allele C*08:01:08 has been extended and shown to be a new silent variant of the C*08:22 protein group. The allele name C*08:01:08 has been abandoned and the sequence renamed C*08:22:02. All new and confirmatory sequences should now be submitted directly to the WHO Nomenclature Committee for Factors of the HLA System via the IPD-IMGT/HLADatabase using the sequence submission tool provided (Robinson et al., 2020). The IPD-IMGT/HLA Databasemay be accessed via www.ebi.ac.uk/ipd/imgt/hla.
自2021年10月、11月和12月命名法更新以来,以下序列已提交给命名委员会(Marsh,2022),并根据商定的政策,被指定为官方等位基因名称(Marsh等人,2010)。所有序列的全部细节将在即将发布的报告中公布。下面列出了新分配的序列(表1)和先前报告序列的确认(表2)。给出了每个序列的登录号,这些登录号可用于从EMBL、GenBank或DDBJ数据库检索序列文件。尽管数据库已经分配了登录号,并且大多数序列已经可用,但作者仍有可能尚未允许发布该序列;在这种情况下,您将不得不直接联系提交作者。与新序列有关的附加信息通常包含在描述这些等位基因的出版物中;表3中给出了描述新HLA序列的最新出版物的列表。最近又发表了295个等位基因,但由于空间考虑,尚未纳入表3(Turner等人,2022)。此外,等位基因A*02:01:08的序列已被扩展,成为一个新的A*02蛋白变体。等位基因名称A*02:01:08已被放弃,序列更名为A*02:1040。此外,等位基因C*08:01:08的序列已被扩展,并显示为C*08:22蛋白组的新的沉默变体。等位基因名称C*08:01:08已被放弃,序列更名为C*08:22:02。现在,应使用提供的序列提交工具,通过IPD-IMGT/HLAD数据库,将所有新序列和验证序列直接提交给世界卫生组织HLA系统因素命名委员会(Robinson等人,2020)。IPD-IMGT/HLA数据库可通过www.ebi.ac.uk/IPD/IMGT/HLA访问。
{"title":"Nomenclature for factors of the HLA system, update January, February and March 2022","authors":"Steven G. E. Marsh","doi":"10.1111/iji.12575","DOIUrl":"10.1111/iji.12575","url":null,"abstract":"The following sequences have been submitted to the Nomenclature Committee since theOctober, November andDecember 2021 nomenclature update (Marsh, 2022) and, following agreed policy, have been assigned official allele designations (Marsh et al., 2010). Full details of all sequences will be published in a forthcoming report. Below are listed the newly assigned sequences (Table 1) and confirmations of previously reported sequences (Table 2). The accession number of each sequence is given and these can be used to retrieve the sequence files from the EMBL, GenBank or DDBJ data libraries. Although accession numbers have been assigned by the data-libraries and most sequences are already available, there is still the possibility that an author may not yet have allowed the sequence to be released; in such a case you will have to contact the submitting author directly. Additional information pertaining to new sequences is often included in the publications describing these alleles; a listing of recent publications that describe new HLA sequences is given in Table 3. An additional 295 alleles were recently published but have not been included in Table 3 due to space considerations (Turner et al., 2022). In addition, the sequence for the allele A*02:01:08 has been extended to become a new A*02 protein variant. The allele name A*02:01:08 has been abandoned and the sequence renamed A*02:1040. Furthermore, the sequence for the allele C*08:01:08 has been extended and shown to be a new silent variant of the C*08:22 protein group. The allele name C*08:01:08 has been abandoned and the sequence renamed C*08:22:02. All new and confirmatory sequences should now be submitted directly to the WHO Nomenclature Committee for Factors of the HLA System via the IPD-IMGT/HLADatabase using the sequence submission tool provided (Robinson et al., 2020). The IPD-IMGT/HLA Databasemay be accessed via www.ebi.ac.uk/ipd/imgt/hla.","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41856220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China TAP和hla - 1基因组合与中国汉族慢性丙型肝炎病毒感染的相关性研究
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-04-29 DOI: 10.1111/iji.12574
Yufen Tao, Xue Han, Nannan Liu, Lei Shi, Li Shi, Shuyuan Liu, Yufeng Yao

Host immune system genes play key roles in the progression of chronic hepatitis C virus (HCV) infection. Transporters associated with antigen processing (TAP) play an important role in the loading of viral peptides onto MHC class I molecules. This study aimed to investigate the association between TAP gene polymorphisms and chronic HCV in a Chinese Han population. A total of 232 chronic hepatitis C (CHC) patients and 362 healthy individuals were recruited from the Han population in Yunnan province in southwest China, and a TaqMan SNP genotyping assay was used to detect six single nucleotide polymorphisms (SNPs) of TAP1 and three SNPs of TAP2 genes. The association of the TAP gene with CHC was analysed at the allele, genotype, and haplotype levels. There were no significant differences in the allele and genotype frequencies of these SNPs in the TAP gene between CHC patients and controls after Bonferroni correction. A novel TAP1 allele (TAP1*unknown_1: rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: G-G-A-G-G-G) was only present in the CHC group, and this allele significantly increased susceptibility to CHC (= .005, odds ratio [OR] = 11.105. 95% confidence interval [CI]: 1.362–90.558). Homozygous TAP1*03:01/TAP1*03:01 was observed only in the CHC group that exhibited an obvious risk for CHC (= .002, OR = 9.637, 95% CI: 1.153–80.574). And the haplotype TAP1*unknown_1-TAP2*01:01 was only present in the CHC group and indicated a significant risk for CHC (= .002, OR = 9.498, 95% CI: 1.140–79.149). We observed significant interactions among HLA-A, -B,C, TAP1, and TAP2 alleles, and combination analysis revealed that the combination of TAP1*01:01-TAP2*01:01-HLA-B*35:01 was only present in the control group (2.2%) and resulted in significantly increased resistance to CHC (= .002, OR = 0.096, 95% CI: 0.012–0.759). Whereas, the combination of TAP1*01:01-TAP2*01:01-HLA-C*07:02 and TAP1*03:01-TAP2*01:01-HLA-C*01:02 increased the susceptibility to CHC significantly (= .001, OR = 2.016, 95% CI: 1.309–3.106 and = .002, OR = 8.070, 95% CI: 1.018–63.997, respectively). Our results indicated that TAP and HLA-I may exert a combined effect on CHC susceptibility in the Chinese Han population.

宿主免疫系统基因在慢性丙型肝炎病毒(HCV)感染的进展中起关键作用。与抗原加工相关的转运蛋白(TAP)在病毒肽装载到MHC I类分子中起着重要作用。本研究旨在探讨TAP基因多态性与中国汉族人群慢性HCV之间的关系。从中国西南部云南省汉族人群中招募了232例慢性丙型肝炎(CHC)患者和362名健康人群,采用TaqMan SNP基因分型方法检测了TAP1基因的6个单核苷酸多态性(SNP)和TAP2基因的3个SNP。在等位基因、基因型和单倍型水平上分析TAP基因与CHC的相关性。经Bonferroni校正后,CHC患者与对照组TAP基因中这些snp的等位基因频率和基因型频率无显著差异。一个新的TAP1等位基因(TAP1*unknown_1: rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: G-G-A-G-G-G - g)仅在CHC组中存在,该等位基因显著增加CHC的易感性(p = 0.005,优势比[OR] = 11.105)。95%可信区间[CI]: 1.362-90.558)。纯合子TAP1*03:01/TAP1*03:01仅在CHC组中存在明显的CHC风险(p = 0.002, OR = 9.637, 95% CI: 1.53 ~ 80.574)。单倍型TAP1*unknown_1-TAP2*01:01仅存在于CHC组,提示CHC风险显著(p = 0.002, OR = 9.498, 95% CI: 1.140 ~ 79.149)。我们观察到HLA-A、-B、C、TAP1和TAP2等位基因之间存在显著的相互作用,联合分析显示,TAP1*01:01-TAP2*01:01-HLA-B*35:01的组合仅在对照组(2.2%)存在,并导致对CHC的耐药性显著增加(p = 0.002, OR = 0.096, 95% CI: 0.012-0.759)。而TAP1*01:01-TAP2*01:01-HLA-C*07:02和TAP1*03:01-TAP2*01:01-HLA-C*01:02组合可显著提高CHC易感性(p = 0.001, OR = 2.016, 95% CI: 1.309 ~ 3.106和p = 0.002, OR = 8.070, 95% CI: 1.018 ~ 63.997)。我们的结果表明TAP和hla - 1可能对中国汉族人群的CHC易感性起联合作用。
{"title":"Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China","authors":"Yufen Tao,&nbsp;Xue Han,&nbsp;Nannan Liu,&nbsp;Lei Shi,&nbsp;Li Shi,&nbsp;Shuyuan Liu,&nbsp;Yufeng Yao","doi":"10.1111/iji.12574","DOIUrl":"10.1111/iji.12574","url":null,"abstract":"<p>Host immune system genes play key roles in the progression of chronic hepatitis C virus (HCV) infection. Transporters associated with antigen processing (TAP) play an important role in the loading of viral peptides onto MHC class I molecules. This study aimed to investigate the association between <i>TAP</i> gene polymorphisms and chronic HCV in a Chinese Han population. A total of 232 chronic hepatitis C (CHC) patients and 362 healthy individuals were recruited from the Han population in Yunnan province in southwest China, and a TaqMan SNP genotyping assay was used to detect six single nucleotide polymorphisms (SNPs) of <i>TAP1</i> and three SNPs of <i>TAP2</i> genes. The association of the <i>TAP</i> gene with CHC was analysed at the allele, genotype, and haplotype levels. There were no significant differences in the allele and genotype frequencies of these SNPs in the <i>TAP</i> gene between CHC patients and controls after Bonferroni correction. A novel <i>TAP1</i> allele (<i>TAP1*unknown_1</i>: rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: G-G-A-G-G-G) was only present in the CHC group, and this allele significantly increased susceptibility to CHC (<i>p </i>= .005, odds ratio [OR] = 11.105. 95% confidence interval [CI]: 1.362–90.558). Homozygous <i>TAP1*03:01/TAP1*03:01</i> was observed only in the CHC group that exhibited an obvious risk for CHC (<i>p </i>= .002, OR = 9.637, 95% CI: 1.153–80.574). And the haplotype <i>TAP1*unknown_1-TAP2*01:01</i> was only present in the CHC group and indicated a significant risk for CHC (<i>p </i>= .002, OR = 9.498, 95% CI: 1.140–79.149). We observed significant interactions among <i>HLA-A</i>, <i>-B</i>,<i>C</i>, <i>TAP1</i>, and <i>TAP2</i> alleles, and combination analysis revealed that the combination of <i>TAP1*01:01-TAP2*01:01-HLA-B*35:01</i> was only present in the control group (2.2%) and resulted in significantly increased resistance to CHC (<i>p </i>= .002, OR = 0.096, 95% CI: 0.012–0.759). Whereas, the combination of <i>TAP1*01:01-TAP2*01:01-HLA-C*07:02</i> and <i>TAP1*03:01-TAP2*01:01-HLA-C*01:02</i> increased the susceptibility to CHC significantly (<i>p </i>= .001, OR = 2.016, 95% CI: 1.309–3.106 and <i>p </i>= .002, OR = 8.070, 95% CI: 1.018–63.997, respectively). Our results indicated that TAP and HLA-I may exert a combined effect on CHC susceptibility in the Chinese Han population.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41679148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erythropoiesis signature and ubiquitin-mediated proteolysis are enriched in systematic juvenile idiopathic arthritis 红细胞生成特征和泛素介导的蛋白水解在系统性幼年特发性关节炎中丰富
IF 2.2 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-03-07 DOI: 10.1111/iji.12573
Wenping Liu, Dawei Wen, Ziyi Liu, Kunyu Wang, Jibo Wang

Systemic Juvenile Idiopathic Arthritis (sJIA) is a distinctive subtype of Juvenile Idiopathic Arthritis (JIA). The pathogenesis of sJIA is still unclear with the limited treatment options. Although previous bioinformatics analyses have identified some genetic factors underlying sJIA, these studies were mostly single centre with a small sample size and the results were often inconsistent. Herein, we combined two data sets of GSE20307 and GSE21521 and select the matrix of patients diagnosed as sJIA in it for further analysis. The GSE20307 and GSE21521 matrixes downloaded from the Gene Expression Omnibus (GEO) were analysed using online tools GEO2R, Venny, Metascape, STRING and Cytoscape to identify differentially expressed genes (DEGs), enrichment pathways, protein–protein interaction (PPI), main module and hub genes between sJIA individuals and healthy controls. A total of 289 overlapping genes (consisting of 41 downregulated genes and 248 upregulated genes) were identified. Hub genes were primarily related to erythropoiesis. And the KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis of overlapping DEGs were mainly involved in malaria and non-small cell lung cancer. Besides, DEGs in main module were involved in ubiquitin-mediated proteolysis. Our study suggests that the erythropoiesis signature indeed exists in sJIA similar to previous reports. And ubiquitin-mediated proteolysis is important in sJIA.

系统性幼年特发性关节炎(sJIA)是幼年特发性关节炎(JIA)的一个独特亚型。sJIA的发病机制尚不清楚,治疗方案有限。虽然以前的生物信息学分析已经确定了sJIA的一些遗传因素,但这些研究大多是单中心的,样本量小,结果往往不一致。本文结合GSE20307和GSE21521两组数据集,选取其中诊断为sJIA的患者矩阵进行进一步分析。使用在线工具GEO2R、Venny、metscape、STRING和Cytoscape分析从基因表达Omnibus (GEO)下载的GSE20307和GSE21521基质,鉴定sJIA个体与健康对照之间的差异表达基因(DEGs)、富集途径、蛋白-蛋白相互作用(PPI)、主要模块和枢纽基因。共鉴定出289个重叠基因(包括41个下调基因和248个上调基因)。Hub基因主要与红细胞生成有关。而KEGG (Kyoto Encyclopedia of Genes And Genomes)分析的重叠deg主要涉及疟疾和非小细胞肺癌。此外,主要模块中的deg参与了泛素介导的蛋白水解。我们的研究表明sJIA确实存在红细胞生成特征,这与之前的报道相似。泛素介导的蛋白水解在sJIA中很重要。
{"title":"Erythropoiesis signature and ubiquitin-mediated proteolysis are enriched in systematic juvenile idiopathic arthritis","authors":"Wenping Liu,&nbsp;Dawei Wen,&nbsp;Ziyi Liu,&nbsp;Kunyu Wang,&nbsp;Jibo Wang","doi":"10.1111/iji.12573","DOIUrl":"10.1111/iji.12573","url":null,"abstract":"<p>Systemic Juvenile Idiopathic Arthritis (sJIA) is a distinctive subtype of Juvenile Idiopathic Arthritis (JIA). The pathogenesis of sJIA is still unclear with the limited treatment options. Although previous bioinformatics analyses have identified some genetic factors underlying sJIA, these studies were mostly single centre with a small sample size and the results were often inconsistent. Herein, we combined two data sets of GSE20307 and GSE21521 and select the matrix of patients diagnosed as sJIA in it for further analysis. The GSE20307 and GSE21521 matrixes downloaded from the Gene Expression Omnibus (GEO) were analysed using online tools GEO2R, Venny, Metascape, STRING and Cytoscape to identify differentially expressed genes (DEGs), enrichment pathways, protein–protein interaction (PPI), main module and hub genes between sJIA individuals and healthy controls. A total of 289 overlapping genes (consisting of 41 downregulated genes and 248 upregulated genes) were identified. Hub genes were primarily related to erythropoiesis. And the KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis of overlapping DEGs were mainly involved in malaria and non-small cell lung cancer. Besides, DEGs in main module were involved in ubiquitin-mediated proteolysis. Our study suggests that the erythropoiesis signature indeed exists in sJIA similar to previous reports. And ubiquitin-mediated proteolysis is important in sJIA.</p>","PeriodicalId":14003,"journal":{"name":"International Journal of Immunogenetics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45857072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Immunogenetics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1